Top Markets
Coin of the day
Mountain Valley MD Holdings Inc. Mountain Valley MD Holdings Inc.

Mountain Valley MD Holdings Inc.

MVMD
Rang in Aktien #30438
Mountain Valley MD Holdings Inc., operating through its subsidiary Mountain... Mountain Valley MD Holdings Inc., operating through its subsidiary Mountain Valley MD Inc., functions as a health and wellness enterprise. The company focuses on deploying and licensing its proprietary innovations to external entities within the pharmaceutical, vaccine, and nutritional supplement sectors. Its portfolio encompasses Quicksome, an advanced technology for oral drug formulation and delivery; Quicksol, designed for enhancing solubility; and a dose-sparing adjuvant. Additionally, the firm is actively developing IM032, a compound currently being evaluated in male beagle dogs to assess intramuscular versus subcutaneous administration methods. Mountain Valley MD Holdings Inc. is headquartered in Concord, Canada.
Aktienkurs
$0.0477059
Marktkapitalisierung
$16.81M
Veränderung (1 Tag)
8.33%
Veränderung (1 Jahr)
229.16%
Land
CA
Handel Mountain Valley MD Holdings Inc. (MVMD)

Kategorie

EPS für Mountain Valley MD Holdings Inc. (MVMD)
EPS zum 2026 TTM: 0
Laut den aktuellen Finanzberichten und dem Aktienkurs von Mountain Valley MD Holdings Inc. beträgt das aktuelle EPS des Unternehmens (TTM) 0. Am Ende des Jahres 2026 betrug das EPS 0 gleich wie dem EPS von 2026, das 0 betrug.
EPS-Verlauf von Mountain Valley MD Holdings Inc. von 2026 bis 2026
EPS am Ende jedes Jahres
Jahr EPS ändert
Nicht genügend Daten für die angegebenen Daten.
EPS für ähnliche Unternehmen oder Wettbewerber